67457-256 : Bivalirudin 250 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution


NDC: 67457-256
Labeler: Mylan Institutional LLC
Product Type: Human Prescription Drug
Drug Name:  Bivalirudin
Dosage Form: Intravenous Injection, Powder, Lyophilized, for Solution
Application #: ANDA202471
Rev. Date: 


NDC Package Codes:

  • 67457-256-10: 10 VIAL, SINGLE‑DOSE IN 1 CARTON (67457‑256‑10) > 5 ML IN 1 VIAL, SINGLE‑DOSE (67457‑256‑00)

Active Ingredients:

  • Bivalirudin

Dosage Strength:

  • 250 mg/5mL

Pharmaceutical Classes:

  • Anti-coagulant [EPC]
  • Direct Thrombin Inhibitor [EPC]
  • Thrombin Inhibitors [MoA]

Related Products:

Based on records with the same trade name.
  • 0409-8300 Bivalirudin 250 mg Intravenous Injection, Powder, Lyophilized, for Solution by Hospira, Inc.
  • 0781-3158 Bivalirudin 250 mg Intravenous Injection, Powder, Lyophilized, for Solution by Sandoz
  • 0781-9158 Bivalirudin 250 mg Intravenous Injection, Powder, Lyophilized, for Solution by Sandoz
  • 16729-275 Bivalirudin 250 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Accord Healthcare, Inc.
  • 25021-405 Bivalirudin 250 mg Intravenous Injection, Powder, Lyophilized, for Solution by Sagent Pharmaceuticals
  • 42023-622 Bivalirudin 250 mg Intravenous Injection, Solution by Par Pharmaceutical, Inc.
  • 52958-034 Bivalirudin 250 mg Intravenous Injection, Powder, Lyophilized, for Solution by Hainan Shuangcheng Pharmaceuticals Co., Ltd.
  • 55111-652 Bivalirudin 250 mg Intracavernous Injection by Dr. Reddy's Laboratories Limited
  • 55150-210 Bivalirudin 250 mg Intravenous Injection, Powder, Lyophilized, for Solution by Auromedics Pharma LLC
  • 60505-6101 Bivalirudin 250 mg Intravenous Injection, Powder, Lyophilized, for Solution by Apotex Corp
  • 63323-562 Bivalirudin 250 mg Intravenous Injection, Powder, Lyophilized, for Solution by Fresenius Kabi USA, LLC
  • 69097-601 Bivalirudin 250 mg Intravenous Injection by Cipla USA Inc.
  • 70436-025 Bivalirudin 250 mg Intravenous Injection, Powder, Lyophilized, for Suspension by Slate Run Pharmaceuticals, LLC
  • 70511-141 Bivalirudin 250 mg Intravenous Injection, Solution by Maia Pharmaceuticals, Inc.
  • 70511-142 Bivalirudin 250 mg Intravenous Injection, Solution by Maia Pharmaceuticals, Inc.
  • 70860-402 Bivalirudin 250 mg Intravenous Injection, Powder, Lyophilized, for Solution by Athenex Pharmaceutical Division, LLC.
  • 71288-427 Bivalirudin 250 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Meitheal Pharmaceuticals Inc.
  • 72572-035 Bivalirudin 250 mg Intravenous Injection, Powder, Lyophilized, for Solution by Civica, Inc.
  • 75929-217 Bivalirudin 250 mg Intravenous Injection, Powder, Lyophilized, for Solution by Pharma Packaging Solutions, LLC Dba Tjoapack LLC
  • 83634-400 Bivalirudin 250 mg Intravenous Injection, Powder, Lyophilized, for Solution by Avenacy, Inc.

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 67457-256 QR Code

< Prev: 67457-255Next: 67457-257 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.